G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 81 filers reported holding G1 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $103,453 | -44.9% | 38,602 | +11.6% | 0.00% | – |
| Q4 2022 | $187,818 | – | 34,589 | +3458800.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2022 | $168,000 | -22.9% | 22,129 | +3.5% | 0.00% | – |
| Q4 2021 | $218,000 | -40.6% | 21,385 | -22.0% | 0.00% | – |
| Q3 2021 | $367,000 | -18.1% | 27,412 | +34.5% | 0.00% | – |
| Q2 2021 | $448,000 | -19.1% | 20,378 | -11.5% | 0.00% | – |
| Q1 2021 | $554,000 | -57.1% | 23,022 | -68.0% | 0.00% | -100.0% |
| Q4 2020 | $1,291,000 | +27.6% | 71,840 | -18.0% | 0.00% | 0.0% |
| Q3 2020 | $1,012,000 | -8.5% | 87,660 | +92.2% | 0.00% | 0.0% |
| Q2 2020 | $1,106,000 | +346.0% | 45,603 | +103.2% | 0.00% | – |
| Q1 2020 | $248,000 | -66.6% | 22,444 | -20.0% | 0.00% | -100.0% |
| Q4 2019 | $742,000 | +30.6% | 28,057 | +12.5% | 0.00% | – |
| Q3 2019 | $568,000 | +6.8% | 24,949 | +43.7% | 0.00% | – |
| Q2 2019 | $532,000 | +112.8% | 17,365 | +15.2% | 0.00% | – |
| Q1 2019 | $250,000 | +14.2% | 15,075 | +31.3% | 0.00% | – |
| Q4 2018 | $219,000 | -78.2% | 11,481 | -40.2% | 0.00% | -100.0% |
| Q3 2018 | $1,004,000 | +34.9% | 19,189 | +12.1% | 0.00% | 0.0% |
| Q2 2018 | $744,000 | +154.8% | 17,118 | +117.4% | 0.00% | – |
| Q1 2018 | $292,000 | – | 7,874 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 719,985 | $31,291,000 | 2.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 72,000 | $3,121,000 | 1.20% |
| EMERALD ADVISERS, LLC | 506,424 | $22,009,000 | 0.83% |
| Virtus ETF Advisers LLC | 18,103 | $787,000 | 0.70% |
| Birchview Capital, LP | 22,000 | $956,000 | 0.65% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 352,053 | $15,300,000 | 0.55% |
| Hillhouse Capital Management | 699,431 | $30,397,000 | 0.52% |
| Rock Springs Capital Management LP | 300,000 | $13,038,000 | 0.50% |
| BB BIOTECH AG | 352,607 | $15,324,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 287,000 | $12,473,000 | 0.44% |